Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) studyD V Skarlos, G Fountzilas, N Pavlidis, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 3, 2007
Recombinant human erythropoietin for platinum-based chemotherapy-induced anaemia: A single-centre randomised studyG Aravantinos, H Linardou, D Makridaki, et al.Oncology|October 21, 1998
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility studyG Fountzilas, C Nicolaides, G Aravantinos, et al.European Urology|January 1, 1997
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group studyD V Skarlos, G Aravantinos, E Linardou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancerG Aravantinos, M A Dimopoulos, P Kosmidis, et al.Anticancer Research|August 10, 2002
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancerE Andreopoulou, D Andreopoulos, K Adamidis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerG Aravantinos, D Bafaloukos, G Fountzilas, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceD Pectasides, G Fountzilas, G Aravantinos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, D Mavroudis, N Tsavaris, et al.Anticancer Research|June 29, 2007
Kit expression in male germ cell tumorsM Nikolaou, C Valavanis, G Aravantinos, et al.Pageof 9